F543-0593 Screening compound: N-{5-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylphenyl}furan-2-carboxamide

F543-0593 Screening compound: N-{5-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylphenyl}furan-2-carboxamide
F543-0593 Screening compound: N-{5-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylphenyl}furan-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F543-0593
N-{5-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylphenyl}furan-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F543-0593

Molecular Formula

C26H23N5O4 (C26 H23 N5 O4)

Compound Name

N-{5-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylphenyl}furan-2-carboxamide

IUPAC name

N-{5-[3-(1-cyclopentyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)-124-oxadiazol-5-yl]-2-methylphenyl}furan-2-carboxamide

SMILES

Cc(ccc(-c1nc(-c(cc2)cc(N3)c2N(C2CCCC2)C3=O)no1)c1)c1NC(c1ccco1)=O

InChI

InChI=1S/C26H23N5O4/c1-15-8-9-17(14-19(15)27-24(32)22-7-4-12-34-22)25-29-23(30-35-25)16-10-11-21-20(13-16)28-26(33)31(21)18-5-2-3-6-18/h4,7-14,18H,2-3,5-6H2,1H3,(H,27,32)(H,28,33)

InChI Key

FHAUWIYWSRLNQR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27175282

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

469.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.696

Distribution Coefficient, logD

5.696

Water Solubility, LogSw

-5.38

Polar Surface Area

89.027

Acid Dissociation Constant (pKa)

11.99

Base Dissociation Constant (pKb)

-1.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

F543-0593 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cardiovascular
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with F543-0593 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F543-0593?
Check Price and Availability of F543-0593, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F543-0593 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F543-0593
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F543-0593
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F543-0593 available by request